Statistics
Publications
13
Citations
1.2K
H-Index
13
Active since
2014
Kelly Mitchell is an author at Albert Einstein College of Medicine specializing in molecular oncology, oncology, and medicine.
Publications per year
2014–2024
13
13
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
Daniela Ben Neriah, Adrien Senecal, Lumie Benard et al. · Science Translational Medicine · 2018 · 250 citations · Full text
Medicine, Oncology, Pharmacology +15
New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
Ujunwa Cynthia Okoye-Okafor, Boris Bartholdy, Jessy Cartier et al. · Nature Chemical Biology · 2015 · 176 citations · Full text
Medicine, Hematology, Oncology +12
Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia
Denis E. Reyna, Thomas P. Garner, Andrea López et al. · Cancer Cell · 2017 · 163 citations · Full text
Medicine, Cancer Biology, Oncology +14
Pharmacological inhibition of the transcription factor PU.1 in leukemia
Iléana Antony‐Debré, Ananya Paul, Joana Leite et al. · Journal of Clinical Investigation · 2017 · 121 citations · Full text
1–5 of 13